Achiraya Teyateeti

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Brain Metastases

Prognostic Factors

Radiation Therapy

Top Venues

Journal of hepatocellular carcinoma

Neuro-oncology practice

Neuro-oncology advances

Journal of neurological surgery. Part B, Skull base

Faculty of Medicine Siriraj Hospital, Mahidol University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculty of Medicine Siriraj Hospital, Mahidol University Jun 01 2013

Thailand

Instructor :: Division of Radiation Oncology, Department of Radiology

Faculty of Medicine Siriraj Hospital, Mahidol University Apr 01 2010 - May 31 2013

Thailand

Resident :: Division of Radiation Oncology, Department of Radiology

Publications

Achiraya Teyateeti, Paul D Brown, Anita Mahajan, Nadia N Laack, Bruce E Pollock
Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery. Neuro-oncology advances 3 (1) (2021)
Achiraya Teyateeti, Christopher Salvatore Graffeo, Avital Perry, Eric J Tryggestad, Paul D Brown, Bruce E Pollock, Michael J Link
The Effect of Prescription Isodose Variation on Tumor Control and Toxicities in Stereotactic Radiosurgery for Sporadic Vestibular Schwannoma: Propensity Score-Matched Case-Control Study. Journal of neurological surgery. Part B, Skull base 83 (2) (2021)
Achiraya Teyateeti, Connie S Geno, Scott S Stafford, Anita Mahajan, Elizabeth S Yan, Kenneth W Merrell, Nadia N Laack, Ian F Parney, Paul D Brown, Krishan R Jethwa
Does the dural resection bed need to be irradiated? Patterns of recurrence and implications for postoperative radiotherapy for temporal lobe gliomas. Neuro-oncology practice 8 (2) (2020)
Ajalaya Teyateeti, Armeen Mahvash, James P Long, Mohamed E Abdelsalam, Rony Avritscher, Beth Chasen, Ahmed O Kaseb, Joshua D Kuban, Ravi Murthy, Bruno C Odisio, Achiraya Teyateeti, Homer A Macapinlac, Srinivasan Cheenu Kappadath
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients. Journal of hepatocellular carcinoma 7 (2020)